Has Chau Vu, MD received payments from drug or device companies?

Yes. Drug and device makers reported $141,388 in general payments to Chau Vu, MD across 541 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Chau Vu, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Chau Vu, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Chau Vu, MD

Interventional Pain Medicine · Santa Rosa, CANPI 1538508841

Payments from drug & device makers

$141,388in general payments, 2019–2025

Across 541 payments — averaging $261.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Saluda Medical Americas, Inc.$105K
Painteq LLC$20K
Abbott$4K
Nevro Corp.$3K
Vertos Medical, Inc.$2K
Vertiflex, Inc.$1K
plus $7K from 35 others

$845in research payments, 2019–2025

Across 13 payments — averaging $64.98 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Saluda Medical Americas, Inc.$845

What the payments were for

Consulting fees$82,00758%
Travel & lodging$17,64812%
Food & beverage$28,22520%
Education$13,47310%
Entertainment$350%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Saluda Medical Americas, Inc.	157	$104,898
Painteq LLC	83	$19,870
Abbott	95	$4,187
Nevro Corp.	46	$2,891
Vertos Medical, Inc.	8	$1,579
Vertiflex, Inc.	7	$1,392
SPR Therapeutics, Inc	11	$1,081
Biotronik NRO, Inc.	15	$933
Boston Scientific	15	$662
Stimwave Technologies Incorporated	7	$575
Bioventus LLC	6	$439
MML US, Inc.	4	$437
Medtronic	4	$333
Relievant Medsystems, Inc.	4	$242
Collegium Pharmaceutical, Inc.	16	$213
Daiichi Sankyo Inc.	12	$174
Brixton Biosciences, Inc.	2	$174
Globus Medical	2	$174
Curonix LLC	1	$99
Amgen	4	$93
Si-bone, Inc.	1	$86
Bausch Health US, LLC	4	$85
Pfizer	5	$85
Teva Pharmaceuticals USA, Inc.	4	$83
Stryker	2	$82
Scilex Pharmaceuticals Inc.	3	$63
Pacira Pharmaceuticals Incorporated	1	$58
Nalu Medical, Inc.	3	$51
Assertio Therapeutics, Inc.	3	$43
Foundation Fusion Solutions, LLC	1	$35
MDD US Operations, LLC	2	$34
Spinal Simplicity, LLC	1	$29
AbbVie	1	$29
Arbor Pharmaceuticals, Inc.	2	$28
Zyla Life Sciences, Inc.	2	$27
Biodelivery Sciences International, Inc.	2	$26
GRT US Holding, Inc.	1	$26
Fidia Pharma USA Inc.	1	$20
Lilly USA, LLC	1	$18
Kaleo, Inc.	1	$18
Pacira Therapeutics, Inc.	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Evoke SCS$51,731
Evoke$50,816
PAINTEQ$17,518
mild Device Kit$1,420
Senza Spinal Cord Stimulation System$1,347
Superion ISS$1,242
PROCLAIM$1,077
SPRINT PNS System$832
Prospera$634
Senza$365
ReActiv8$341
ETERNA$318
CFNS StimQ Peripheral Nerve StimulatorSystem$284
SCS FreedonSpinal Cord Stimulator$284
Proclaim Family of SCS IPGs$273
Intracept$261
Stimrouter Implantable Kit$254
Omnia$249
HeartMate 3 Left Ventricular Assist Device$240
Proclaim IPG$178

How this compares

$141,388 in reported general payments places this provider in the 90th percentile of 188 interventional pain medicine providers in California.

See all interventional pain medicine providers in California →

Medicare billing

Part B allowed, 2024

$446,807

Medicare patients

458

Services billed

6,353

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Buprenorphine	74	$16,763
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	297	$5,828
OxycontinOxycodone Hcl	11	$4,623
Celecoxib	169	$4,216
Gabapentin	295	$3,859
Pregabalin	138	$3,192
Naloxone Hcl	33	$2,074
Lidocaine	27	$1,882
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl	16	$1,802
Diclofenac Sodium	55	$1,768
Buprenorphine Hcl	43	$1,433
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	62	$1,423
Oxycodone Hcl	104	$1,187
Tizanidine Hcl	80	$935
Duloxetine Hcl	35	$751

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Santa Rosa

Harjot BhandalSanta Rosa$96K
Sheldon JordanSanta Monica$3.1M
Ezekiel FinkBeverly Hills$2.3M
Matthew DotyOroville$1.3M
Tim LeierRancho Mirage$749K
Pragya GuptaEscondido$647K
Michael Verdolinla Mesa$563K
Standiford HelmOrange$476K
Patrick BuchananCamarillo$453K
Roy BrownlowSan Diego$452K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →